146 related articles for article (PubMed ID: 20871458)
1. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine: safety profile and efficacy in the early postoperative period.
Fahim DK; Whitehead WE; Curry DJ; Dauser RC; Luerssen TG; Jea A
Neurosurgery; 2010 Nov; 67(5):1195-204; discussion 1204. PubMed ID: 20871458
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
[TBL] [Abstract][Full Text] [Related]
3. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis.
Allen RT; Lee YP; Stimson E; Garfin SR
Spine (Phila Pa 1976); 2007 Dec; 32(26):2996-3006. PubMed ID: 18091493
[TBL] [Abstract][Full Text] [Related]
5. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
6. Safety, efficacy, and dosing of recombinant human bone morphogenetic protein-2 for posterior cervical and cervicothoracic instrumented fusion with a minimum 2-year follow-up.
Hamilton DK; Smith JS; Reames DL; Williams BJ; Chernavvsky DR; Shaffrey CI
Neurosurgery; 2011 Jul; 69(1):103-11; discussion 111. PubMed ID: 21368688
[TBL] [Abstract][Full Text] [Related]
7. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
8. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.
Vaidya R; Sethi A; Bartol S; Jacobson M; Coe C; Craig JG
J Spinal Disord Tech; 2008 Dec; 21(8):557-62. PubMed ID: 19057248
[TBL] [Abstract][Full Text] [Related]
9. Use of recombinant human bone morphogenetic protein-2 to enhance posterior cervical spine fusion at 2 years of age: technical note.
Oluigbo CO; Solanki GA
Pediatr Neurosurg; 2008; 44(5):393-6. PubMed ID: 18703886
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2.
O'Shaughnessy BA; Kuklo TR; Ondra SL
Spine (Phila Pa 1976); 2008 Mar; 33(5):E132-9. PubMed ID: 18317180
[TBL] [Abstract][Full Text] [Related]
12. Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors.
Lam SK; Sayama C; Harris DA; Briceño V; Luerssen TG; Jea A
J Neurosurg Pediatr; 2014 Nov; 14(5):476-85. PubMed ID: 25171721
[TBL] [Abstract][Full Text] [Related]
13. Complications associated with recombinant human bone morphogenetic protein use in pediatric craniocervical arthrodesis.
Lindley TE; Dahdaleh NS; Menezes AH; Abode-Iyamah KO
J Neurosurg Pediatr; 2011 May; 7(5):468-74. PubMed ID: 21529186
[TBL] [Abstract][Full Text] [Related]
14. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
[TBL] [Abstract][Full Text] [Related]
15. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
Hiremath GK; Steinmetz MP; Krishnaney AA
Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
[TBL] [Abstract][Full Text] [Related]
17. Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma.
Shahlaie K; Kim KD
Spine (Phila Pa 1976); 2008 Oct; 33(21):2361-6. PubMed ID: 18827703
[TBL] [Abstract][Full Text] [Related]
18. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
[TBL] [Abstract][Full Text] [Related]
19. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).
McClellan JW; Mulconrey DS; Forbes RJ; Fullmer N
J Spinal Disord Tech; 2006 Oct; 19(7):483-6. PubMed ID: 17021411
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human bone morphogenetic protein-2 as an adjunct for spine fusion in a pediatric population.
Abd-El-Barr MM; Cox JB; Antonucci MU; Bennett J; Murad GJ; Pincus DW
Pediatr Neurosurg; 2011; 47(4):266-71. PubMed ID: 22310349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]